文献速递糖尿病

德国COVID-19第一波期间儿童青少年及年轻成人自身抗体阴性1型糖尿病频率

Frequency of Autoantibody-Negative Type 1 Diabetes in Children, Adolescents, and Young Adults During the First Wave of the COVID-19 Pandemic in Germany.
PubMed 文献 · Diabetes Care · 2021-05-14

基于德国DPV前瞻性随访登记,比较2020年3月1日至6月30日新诊断1型糖尿病的715例儿童青少年及年轻成人( COVID-19大流行期间)与2011-2019年同期的5428例。自身抗体阴性频率2020年为6.6%(95%CI 5.1-8.4),2011-2019年为7.2%(95%CI 6.5-8.0),绝对差-0.68%(90%CI -2.07至0.71;P非劣效=0.023)。结论未发现COVID-19大流行导致自身抗体阴性1型糖尿病新病例显著增加,且其酮酸中毒易感性无差异。

要点

  • 2020年自身抗体阴性1型糖尿病频率6.6%,与2011-2019年7.2%相比未显示非劣效性检验不达标(P=0.023)。
  • COVID-19期间酮酸中毒频率增加在自身抗体阴性与阳性1型糖尿病中相似(调整RR分别为1.28和1.57)。
  • 自身抗体阴性1型糖尿病在疫情前后均未显示对酮酸中毒的特殊易感性。

核心结论

  • 未发现COVID-19大流行导致儿童青少年及年轻成人自身抗体阴性1型糖尿病新病例显著增加。
  • 自身抗体阴性1型糖尿病在疫情前后均未显示对酮酸中毒的特殊易感性。

研究设计与样本

  • 基于德国糖尿病前瞻性随访登记(DPV)的回顾性比较研究。
  • 比较2020年3月1日至6月30日新诊断1型糖尿病的715例与2011-2019年同期5428例。
  • 使用多变量对数二项回归估计调整差异和相对风险,并进行上限非劣效性检验(margin 1%)。

主要发现

  • 2020年自身抗体阴性频率估计为6.6%(95%CI 5.1-8.4),2011-2019年为7.2%(95%CI 6.5-8.0)。
  • 绝对差异为-0.68%(90%CI -2.07至0.71;P上限非劣效=0.023)。
  • COVID-19期间酮酸中毒频率增加在自身抗体阴性和阳性1型糖尿病中相似(调整RR分别为1.28 [95%CI 0.80-2.05]和1.57 [95%CI 1.41-1.75])。

关键数值与推荐

  • 自身抗体阴性频率2020年6.6%(95%CI 5.1-8.4) vs 2011-2019年7.2%(95%CI 6.5-8.0)。
  • 绝对差异-0.68%(90%CI -2.07至0.71;P上限非劣效=0.023)。
  • 酮酸中毒调整RR:自身抗体阴性1.28(95%CI 0.80-2.05),阳性1.57(95%CI 1.41-1.75)。

临床怎么用

  • 在COVID-19大流行期间,儿童青少年及年轻成人新诊断1型糖尿病中自身抗体阴性频率未见显著增加。
  • 自身抗体阴性1型糖尿病患者发生酮酸中毒的风险与抗体阳性者相似,疫情前后均无需特殊担忧。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The aim of this study was to investigate the frequency of newly diagnosed type 1 diabetes without evidence of autoimmunity and the respective frequencies of ketoacidosis in children, adolescents, and young adults during the coronavirus disease 2019 (COVID-19) pandemic in Germany compared with the previous decade. RESEARCH DESIGN AND METHODS: Based on data from the German Diabetes Prospective Follow-up Registry (DPV), we compared data from 715 children, adolescents, and young adults, newly diagnosed with type 1 diabetes during the COVID-19 pandemic in Germany between 1 March and 30 June 2020, with data from 5,428 children, adolescents, and young adults of the same periods from 2011 to 2019. Adjusted differences and relative risks (RRs) of negative β-cell autoantibody test results and diabetic ketoacidosis were estimated using multivariable log-binomial regression analysis. An upper noninferiority test (margin 1%) was applied to evaluate whether the autoantibody-negativity rate in 2020 was not higher than that in 2011 to 2019. RESULTS: The estimated frequencies of autoantibody negativity in 2020 and 2011-2019 were 6.6% (95% CI 5.1-8.4) and 7.2% (95% CI 6.5-8.0), respectively, with an absolute difference of -0.68% (90% CI -2.07 to 0.71; P upper noninferiority = 0.023). The increase of the estimated frequency of diabetic ketoacidosis during the COVID-19 pandemic was similar between autoantibody-negative and -positive type 1 diabetes (adjusted RRs 1.28 [95% CI 0.80-2.05] and 1.57 [1.41-1.75], respectively). CONCLUSIONS: This study found no evidence that the COVID-19 pandemic leads to a significantly increased number of new cases with autoantibody-negative type 1 diabetes in children, adolescents, and young adults. In addition, autoantibody-negative type 1 diabetes showed no particular susceptibility to ketoacidosis, neither before nor during the pandemic.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Kamrath C, Rosenbauer J, Tittel SR, et al. Frequency of Autoantibody-Negative Type 1 Diabetes in Children, Adolescents, and Young Adults During the First Wave of the COVID-19 Pandemic in Germany. Diabetes Care. 2021. PMID: 33990377. doi:10.2337/dc20-2791

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。